Form 4 holding
SVP, Chief Medical Officer
Mersana Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 30,821
- Estimated value
- $83,525
- Report date
- 17 Jan 2023
- Price
- $2.71
- Ownership
- Direct
Arvin Yang - SVP, Chief Medical Officer at Mersana Therapeutics, Inc.
Issuer-level insider activity
- Role
- SVP, Chief Medical Officer
- Issuer ticker
- MRSN
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Arvin Yang since 08 Jul 2025
Reported holdings for Arvin Yang in Mersana Therapeutics, Inc.
Form 4 holding
SVP, Chief Medical Officer
Mersana Therapeutics, Inc.
- Security class
- Restricted stock unit
- Shares / value
- 21,249
- Estimated value
- $57,585
- Report date
- 14 Jan 2023
- Price
- $2.71
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
SVP, Chief Medical Officer
Mersana Therapeutics, Inc.
- Security class
- Stock option (right to buy)
- Shares / value
- 217,500
- Estimated value
- Report date
- 13 Jan 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Arvin Yang in Mersana Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.